Pedmark® (sodium thiosulfate) – New orphan drug approval
September 20, 2022 - The FDA announced the approval of Fennec Pharmaceuticals’ Pedmark (sodium thiosulfate), to reduce the risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localized, non-metastatic solid tumors.
Top